Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Research output: Contribution to journalEditorial

Abstract

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

Original languageEnglish
Article number10
Number of pages3
JournalDrugs in Context
Volume10
DOIs
Publication statusPublished - Jan 2021

Keywords

  • Connective tissue diseases
  • Cyclophosphamide
  • Interstitial lung diseases
  • Mycophenolate
  • Nintedanib
  • Pierfenidone
  • Rituximab

Fingerprint

Dive into the research topics of 'Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue'. Together they form a unique fingerprint.

Cite this